PI3K/mTOR inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PI3K/mTOR inhibitor (unspecified), covering 2017-03-07 to 2017-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]